IRRAS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1604 SEK | -1.11% |
|
-.--% | -.--% |
| 2023 | IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index | CI |
| 2023 | IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index | CI |
Presentation Operator MessageOperator (Operator)Hello, and welcome to the IRRAS Q2 Report 2021...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Companyâs shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 17M | |
| +10.11% | 126B | |
| -5.84% | 11.33B | |
| +6.07% | 9.27B | |
| +37.46% | 5.5B | |
| +8.53% | 3.45B | |
| -8.69% | 2.81B | |
| -6.38% | 2.08B | |
| -10.91% | 2.09B | |
| -23.21% | 1.78B |
- Stock Market
- Equities
- IRRAS Stock
- News IRRAS AB
- Transcript : IRRAS AB, Q2 2021 Earnings Call, Aug 26, 2021